Tozinameran/valproateNeuroleptic malignant syndrome and adrenal insufficiency: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1909卷 / 1期

关键词：

D O I：

10.1007/s40278-022-16821-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：534 / 534

相关论文

共 50 条

[1] ValproateNeuroleptic malignant syndrome: case report
Reactions Weekly, 2017, 1649 (1) : 245 - 245
[2] Thioridazine/valproateNeuroleptic malignant syndrome: case report
Reactions Weekly, 2012, 1413 (1) : 43 - 43
[3] Antipsychotics/valproateNeuroleptic malignant syndrome: case report
Reactions Weekly, 2020, 1814 (1) : 75 - 75
[4] Haloperidol/sodium valproateNeuroleptic malignant syndrome: case report
Reactions Weekly, 2014, 1521 (1) : 81 - 81
[5] Clozapine/aripiprazole/risperidone/valproateNeuroleptic malignant syndrome: case report
Reactions Weekly, 2009, 1236 (1) : 14 - 14
[6] Fluphenazine/sodium-valproateNeuroleptic malignant syndrome: case report
Reactions Weekly, 2021, 1878 (1) : 248 - 248
[7] Olanzapine/valproateNeuroleptic malignant syndrome and increased serum ammonia: case report
Reactions Weekly, 2014, 1500 (1) : 29 - 29
[8] Olanzapine/sodium valproateNeuroleptic malignant syndrome and syndrome of inappropriate antidiuretic hormone: case report
Reactions Weekly, 2013, 1475 (1) : 29 - 29
[9] Haloperidol/olanzapine/valproateNeuroleptic malignant syndrome and bone marrow suppression: case report
Reactions Weekly, 2015, 1559 (1) : 85 - 85
[10] MegestrolPseudotumour cerebri syndrome and adrenal insufficiency: case report
Reactions Weekly, 2022, 1906 (1) : 249 - 249

← 1 2 3 4 5 →